Thursday Jul 2 | Ireland.com
Elan climbs 91% on Johnson deal
Pharmaceutical group Elan saw its share price move 19 per cent in the right direction today, providing the big story of the day on the Iseq index.
Rebel shareholder appointed as non-executive director of Elan
IRISH BIOTECH group Elan last night announced a boardroom shake-up that will see one of the management's most vociferous critics become a non-executive director of the company.
CRH leads Iseq into negative territory
The Iseq index of Irish shares underperformed other European indices today, falling 3.5 per cent as its major stock CRH fell more than 6 per cent.
Lundbeck may have revived its interest in Elan
Danish pharmaceutical firm Lundbeck is understood to be interested in acquiring 4bn Irish drug group Elan.
Biotech Elan may go on market after strategic review
IRISH BIOTECH group Elan may put itself on the market as a result of a strategic review announced yesterday.
Elan says it's looking at sale or merger
Elan says undertakes strategic review Tuesday, January 13 08:45:25 Irish drugs group Elan is to conduct a strategic review of its business, which could - as one of its four stated options - lead to a sale or ...